Hosted on MSN1mon
BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thoughtATM, CDK12, and PALB2 genes, with a view to starting them on PARP inhibitor treatment. In 340 cases, the men's cancer had spread elsewhere (metastasized). Their average age was 69, but ranged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback